Adaptive Biotechnologies Corporation (ADPT)
Adaptive Biotechnologies Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Adaptive Biotechnologies Corporation (ADPT) is a Biotechnology company based in US with a market capitalization of $2.5B. Revenue grew 54.8% year-over-year and free cash flow was negative at -$48.9M. This page tracks ADPT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 619 employees · IPO Jun 27, 2019
Valuation
Valuation & price
$13.18as of May 15, 2026· -41.1% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
11.26
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$2.5B
Market cap
54.8%
Revenue growth (YoY)
74.2%
Gross margin
-$48.9M
Free cash flow (USD)
$53.6M
Net debt
3.1%
Share dilution
0/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2017 → 2025
Free cash flow by year
2017 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
17
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 5, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider sellJun 30, 2026Filing
Insider Sell $3.5M · 10b5-1 PlanBENZENO SHARON · Chief Commercial Ofc Imm Med · $3.5M
- Insider sellJun 29, 2026Filing
Insider Sell $102K · 10b5-1 PlanBOBULSKY SUSAN · Chief Commercial Officer, MRD · $102.5K
- Insider sellJun 29, 2026Filing
Insider Sell $1.1M · 10b5-1 PlanGRIFFIN MICHELLE RENEE · Director · $1.1M
- 8-K eventJun 22, 2026Filing
Convertible Notes Indenture
- Insider sellJun 17, 2026Filing
Insider Sell $1.8M · 10b5-1 PlanROBINS HARLAN S · Chief Scientific Officer · $1.8M
- Insider sellJun 15, 2026Filing
Insider Sell $95K · 10b5-1 PlanBOBULSKY SUSAN · Chief Commercial Officer, MRD · $95K
- 8-K eventJun 15, 2026Filing
Convertible Notes Offering
- 8-K eventJun 9, 2026Filing
Annual Meeting Results
- Insider sellJun 8, 2026Filing
Insider Sell $198K · 10b5-1 PlanBOBULSKY SUSAN · Chief Commercial Officer, MRD · $198K
- Insider sellJun 8, 2026Filing
Insider Sell $695K · 10b5-1 PlanLO FRANCIS · Chief People Officer · $695.1K
Questions
Frequently asked questions
What is Adaptive Biotechnologies Corporation's market cap?
Adaptive Biotechnologies Corporation (ADPT) has a market capitalization of $2.5B.
What is ADPT's P/E ratio?
A meaningful P/E ratio is not available for ADPT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is ADPT's price-to-book (P/B) ratio?
ADPT trades at 11.26 times book value per share.
Are insiders buying ADPT stock?
SEC Form 4 filings show no open-market insider buys at Adaptive Biotechnologies Corporation in the last 90 days (17 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.